Literature DB >> 27919939

Lung Adenocarcinoma in Never Smokers: Problems of Primary Prevention from Aspects of Susceptible Genes and Carcinogens.

Isao Okazaki1,2, Shigemi Ishikawa3, Wataru Ando4, Yasunori Sohara5.   

Abstract

Global statistics estimate that approximately 25% of patients with lung cancer are never smokers. We suggest that genes related to susceptibility to metabolic syndrome were present among those related to susceptibility to lung adenocarcinoma (AC) in never smokers. There are many questions concerning lung AC in never smokers, which is increasing in incidence, with female predominance, good prognosis, unique genes related to susceptibility and good response to treatment with specific agents. The purpose of this review was to investigate the carcinogenesis of lung AC in never smokers focusing on genes related to susceptibility to lung AC and carcinogens, including environmental factors. In order to clarify the carcinogenesis of lung AC in never smokers, the definition of never smokers, survey of environmental tobacco smoke, the presence of the physical characteristics of metabolic syndrome, and other carcinogens should be investigated for primary prevention of lung AC. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Never smoker; environmental tobacco smoke (ETS); lung adenocarcinoma; metabolic syndrome; review; susceptible gene

Mesh:

Year:  2016        PMID: 27919939     DOI: 10.21873/anticanres.11215

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

Review 1.  The epidemiology of lung cancer.

Authors:  Patricia M de Groot; Carol C Wu; Brett W Carter; Reginald F Munden
Journal:  Transl Lung Cancer Res       Date:  2018-06

2.  Isoflavone and soy food intake and risk of lung cancer in never smokers: report from prospective studies in Japan and China.

Authors:  Choy-Lye Chei; Norie Sawada; Nikhil K Khankari; Motoki Iwasaki; Taiki Yamaji; Hui Cai; Taichi Shimazu; Manami Inoue; Xiao-Ou Shu; Wei Zheng; Shoichiro Tsugane
Journal:  Eur J Nutr       Date:  2022-08-01       Impact factor: 4.865

3.  Novel Genetic Associations Between Lung Cancer and Indoor Radon Exposure.

Authors:  Jung Ran Choi; Sang-Baek Koh; Seong Yong Park; Hye Run Kim; Hyojin Lee; Dae Ryong Kang
Journal:  J Cancer Prev       Date:  2017-12-30

Review 4.  Assessing the Current State of Lung Cancer Chemoprevention: A Comprehensive Overview.

Authors:  Md Ashraf-Uz-Zaman; Aditya Bhalerao; Constantinos M Mikelis; Luca Cucullo; Nadezhda A German
Journal:  Cancers (Basel)       Date:  2020-05-17       Impact factor: 6.639

5.  Trends in lung cancer incidence by gender, histological type and stage at diagnosis in Japan, 1993 to 2015: A multiple imputation approach.

Authors:  Phuong The Nguyen; Kota Katanoda; Eiko Saito; Megumi Hori; Tomio Nakayama; Tomohiro Matsuda
Journal:  Int J Cancer       Date:  2022-02-22       Impact factor: 7.316

6.  The importance of programmed death ligand 1 gene expression, epidermal growth factor receptor gene mutations and serum epidermal growth factor receptor levels in Turkish non-small cell lung cancer patients.

Authors:  Akif Turna; Cem Horozoğlu; Öncü Koç Erbaşoğlu; Şeyda Ercan; Özlem Küçükhüseyin; Saime Turan; Mehmet Tolgahan Hakan; Hasan Volkan Kara; Elvin Hekimoğlu; Ümit Zeybek; Ender Coşkunpınar; Canan Cacına; Arzu Ergen; İlhan Yaylım
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-07-03       Impact factor: 0.332

Review 7.  Na/K Pump and Beyond: Na/K-ATPase as a Modulator of Apoptosis and Autophagy.

Authors:  Cassiano Felippe Gonçalves-de-Albuquerque; Adriana Ribeiro Silva; Camila Ignácio da Silva; Hugo Caire Castro-Faria-Neto; Patrícia Burth
Journal:  Molecules       Date:  2017-04-21       Impact factor: 4.411

8.  Necessity of Epigenetic Epidemiology Studies on the Carcinogenesis of Lung Cancer in Never Smokers.

Authors:  Jong-Myon Bae
Journal:  J Prev Med Public Health       Date:  2018-07-08

9.  CtBP1 interacts with SOX2 to promote the growth, migration and invasion of lung adenocarcinoma.

Authors:  Yifei Liu; Tingting Bian; Jia Feng; Li Qian; Xiaoli Li; Qing Zhang; Jianguo Zhang; Daishan Jiang; Jian Liu; Jiahai Shi
Journal:  Oncol Rep       Date:  2019-05-02       Impact factor: 3.906

Review 10.  Towards Machine Learning-Aided Lung Cancer Clinical Routines: Approaches and Open Challenges.

Authors:  Francisco Silva; Tania Pereira; Inês Neves; Joana Morgado; Cláudia Freitas; Mafalda Malafaia; Joana Sousa; João Fonseca; Eduardo Negrão; Beatriz Flor de Lima; Miguel Correia da Silva; António J Madureira; Isabel Ramos; José Luis Costa; Venceslau Hespanhol; António Cunha; Hélder P Oliveira
Journal:  J Pers Med       Date:  2022-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.